PHARMACEUTICAL COMPANIES

Ren in Opioid Crisis
November 3, 2022

Pharmacies Ordered to Pay $650 Million for Role in Opioid Epidemic

A legal battle that has been ongoing for years concluded recently. Two Ohio counties that were inundated with far more opioid pills than residents needed will now receive $650 million from pharmacy corporations actively involved in doling out addictive opioid painkillers to community members.

read more...

Ren in Opioid Crisis
April 12, 2022

Tracing A Network of Crime: How Pharma Distributors Acted as the Middlemen in the Opioid Epidemic

In the now two-decade-long opioid epidemic in the U.S., pharmaceutical opioid manufacturers, pharmacies, and doctors have all come under fire for the role they played in the surge of opioid addiction and death. One group, previously unnoticed and only just now coming under investigation, bears mentioning. As reports have shown, pharmaceutical distributors had just as critical a role in the opioid epidemic as other bad actors.

read more...

Ren in Legislation
January 20, 2022

Pharma Companies Settle to Resolve Opioid Lawsuits

Several major pharma litigations are currently making their way through U.S. courts. One such case just came to a close, unfortunately releasing several pharma giants from all legal liability regarding their role in the devastating opioid epidemic.

read more...

Ren in Legislation
December 1, 2021

New Developments in the Sackler Case Suggest More Needs to be Done to Hold Pharma Magnates Accountable

In the late-1990s and early-2000s, pharmaceutical manufacturers like Purdue Pharma aggressively marketed addictive drugs such as OxyContin, pushing doctors to prescribe them. Today, though it’s known that these companies helped create America’s opioid epidemic, the owners of the companies appear poised to escape accountability.

read more...

Ren in Legislation
October 23, 2021

How the Sackler Family Got Away with Denying Any Responsibility in the Opioid Epidemic

The litigation of Purdue Pharma/the Sacklers is now over. One of the key aspects of the case that deserves full scrutiny is that Purdue’s owners threatened to withdraw settlement funds if they did not achieve personal immunity. In the end, they won.

read more...

Ren in Opioid Crisis
February 11, 2020

Opioid Lawsuits – Where Should Settlement Money Go?

An October 2019 article in USA Today focused on how critical it is that opioid lawsuit settlement dollars are used to treat addiction. This should be a given, to use settlements from pharma companies to treat addicts (especially considering that many addicts would not be addicts were it not for prescription painkillers).

read more...

Ren in Opioid Crisis
November 1, 2019

Expert Testimony, Opioid Drugs, and a 21st Century Epidemic

Within the opioid addiction epidemic in this country, several types of drugs play a role. But opiates take the lead for causing the most harm, for taking the most lives, and for creating the largest public health burden.

read more...

KH
Karen Hadley in Legislation
September 23, 2019

Suboxone Maker to Pay $1.4 BILLION to Settle Illegal Marketing Claims

In July 2019, Pharmaceutical company Reckitt Benckiser Group settled a federal lawsuit that they fraudulently marketed their addiction treatment drug Suboxone. They’ll pay a huge fine but why doesn’t this settlement actually result in justice?

read more...

KH
Karen Hadley in Pharmaceutical Companies
September 1, 2019

Now That the Oklahoma Lawsuit against Johnson & Johnson Is Over—What Happens Now?

In August 2019, Cleveland County Judge Thad Balkman ordered Johnson & Johnson and their subsidiary, Janssen Pharmaceuticals to pay Oklahoma $572 million for the harm their products cause. When the settlement is paid, what will the benefits actually be? Will Oklahomans actually benefit?

read more...

Ren in Legislation
August 22, 2019

Makers of Fentanyl Under Fire for Bribing Doctors

There’s something special and even a little energizing when the bad guy finally gets caught. When the underdog hero somehow manages to win against insurmountable odds.

read more...